Skip to Main Content

Paper Details

Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design.
Eur Respir J
2
2022
Author NameAffiliation
Matthieu Resche-RigonINSERM U, Universite de Paris
  • 1 - 1

Datasets

Release 1.2